Garg Pankaj Kumar, Kaul Pallvi, Choudhary Deepti, Turaga Kiran Kalyan, Singh Mahendra Pal, Tiwari Ajeet Ramamani, Arora Vipin, Agrawal Nishant, Rau Beat, Yendamuri Sai
Department of Surgical Oncology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
J Surg Oncol. 2020 Sep;122(4):579-593. doi: 10.1002/jso.26110. Epub 2020 Jul 15.
This review was aimed to systematically evaluate the available literature on the impact of COVID-19 on cancer care and to critically analyze the diagnostic and therapeutic strategies suggested by various healthcare providers, societies, and institutions. Majority guidelines for various types of cancers favored a delay in treatment or a nonsurgical approach wherever feasible. These guidelines are based on a low level of evidence and have significant discordance for the role and timing of surgery, especially in early tumors.
本综述旨在系统评估关于新冠病毒病(COVID-19)对癌症治疗影响的现有文献,并批判性地分析各类医疗服务提供者、协会和机构所建议的诊断和治疗策略。各类癌症的多数指南都倾向于在可行的情况下推迟治疗或采用非手术方法。这些指南基于低水平证据,对于手术的作用和时机存在显著分歧,尤其是在早期肿瘤方面。